# INVEGA HAFYERA

NDC: 50458-612
Generic name: paliperidone palmitate
Labeler / Manufacturer: Janssen Pharmaceuticals, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE
Routes: INTRAMUSCULAR
Marketing started: 20210830

FDA application: NDA207946

## Active ingredients

- PALIPERIDONE PALMITATE: 1560 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50458-612"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50458-612
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6cd61892-d2cb-434d-83ed-5c1b2c4e7a0b